[Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material]
- PMID: 18785556
[Clinical study of lumbar fusion by hybrid construct of stem cells technique and biodegradable material]
Abstract
Objective: To explorer the effectiveness of enriched bone marrow stem cells technique for lumbar fusion.
Methods: With the randomization and control principles, 2 graft materials [Enrichment bone marrow mesenchymal stem cells hybridized with beta-tri calcium phosphate (composite graft group), autologous iliac crest bone graft (autograft group)] were compared in posterior lumbar fusion procedures. 56 patients with degenerative disc disease, lumbar instability or spinal stenosis, were included. The volume of cells suspension in pre- and post-enrichment and the number of nucleated cells (NCs) were identified. The number of osteoprogenitor cells was estimated by counting the colony-forming units which express alkaline phosphatase (CFUs/ALP+). Then the efficiency of the enrichment was evaluated. Clinical follow-up with roentgenogram and Oswestry scale scores was performed for outcome evaluation.
Results: (249 +/- 31) ml bone marrow per patient from bilateral iliac crests was aspirated peri-operatively. About (43 +/- 11) ml enriched bone marrow was collected. The number of NCs was concentrated from (15.9 +/- 3.3) x 10(6)/ml to (44.1 +/- 10.8) x 10(6)/ml, CFUs/ALP+ was significantly increased from (118 +/- 86)/ml to(486 +/- 305)/ml. The follow-up was about (26.3 +/- 7.5) months. There was no significant differences in age, gender, disease and fusion segments between the two groups. The fusion rate was 93.3% and 96.2% for composite graft group and autograft group, respectively (chi2 = 0.2146, P = 0.6432). There was no difference in operation time between the two group (t = 0.5243, P = 0.6022), but blood loss in composite graft group was more than that in autograft group (t = 6.4664, P < 0.01). Cell salvage for auto-transfusion could transfuse back half of the blood loss during operation. No hematoma or chronic soreness in the bone marrow donor sites of composite graft group occurred, but a little exudation or moderate swelling in the wound happened in 4 cases which disappeared under medical treatment. Meanwhile, 15.4% patients had hematoma in the iliac bone donor site and 26.9% patients had chronic soreness, but no case had wound problem in autograft group. As for Oswestry scale scores, there was no significant difference between the two groups.
Conclusions: The enrichment technique of autologous bone marrow stem cells can greatly increase the concentration of MSCs. It is a rapid and safe method used peri-operatively. The composite material of enriched MSCs and porous beta-TCP is a good bone substitute in posterior spinal fusion.
Similar articles
-
The clinical use of enriched bone marrow stem cells combined with porous beta-tricalcium phosphate in posterior spinal fusion.Biomaterials. 2008 Oct;29(29):3973-82. doi: 10.1016/j.biomaterials.2008.06.026. Epub 2008 Jul 18. Biomaterials. 2008. PMID: 18639333 Clinical Trial.
-
[Instability of lower lumbar treated with posterior lumbar interbody fusion with autologous iliac crest or interbody fusion cage: a comparative study].Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008 Aug;22(8):928-32. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2008. PMID: 18773807 Clinical Trial. Chinese.
-
The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.Spine J. 2008 May-Jun;8(3):457-65. doi: 10.1016/j.spinee.2007.03.012. Epub 2007 May 25. Spine J. 2008. PMID: 17588821 Clinical Trial.
-
Graft options in posterolateral and posterior interbody lumbar fusion.Spine (Phila Pa 1976). 2010 Aug 1;35(17):1629-39. doi: 10.1097/BRS.0b013e3181d25803. Spine (Phila Pa 1976). 2010. PMID: 20628336 Review.
-
Efficacy of different bone volume expanders for augmenting lumbar fusions.Surg Neurol. 2008 Jan;69(1):16-9; discussion 19. doi: 10.1016/j.surneu.2007.03.021. Surg Neurol. 2008. PMID: 18054607 Review.
Cited by
-
Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives.Stem Cells Transl Med. 2012 Mar;1(3):237-47. doi: 10.5966/sctm.2011-0036. Epub 2012 Feb 22. Stem Cells Transl Med. 2012. PMID: 23197783 Free PMC article. Review.
-
Concise Review: Musculoskeletal Stem Cells to Treat Age-Related Osteoporosis.Stem Cells Transl Med. 2017 Oct;6(10):1930-1939. doi: 10.1002/sctm.17-0054. Epub 2017 Aug 18. Stem Cells Transl Med. 2017. PMID: 28834263 Free PMC article. Review.
-
A self-organising biomimetic collagen/nano-hydroxyapatite-glycosaminoglycan scaffold for spinal fusion.J Mater Sci. 2017 Nov;52(21):12574-12592. doi: 10.1007/s10853-017-1229-9. Epub 2017 Jul 28. J Mater Sci. 2017. PMID: 29977095 Free PMC article.
-
Clinical applications of mesenchymal stem cells in chronic diseases.Stem Cells Int. 2014;2014:306573. doi: 10.1155/2014/306573. Epub 2014 Apr 30. Stem Cells Int. 2014. PMID: 24876848 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials